search
Back to results

Further Enhancing Non-pharmacologic Therapy for Incontinence

Primary Purpose

Urge Urinary Incontinence

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Biofeedback, pelvic floor muscle training, fMRI
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urge Urinary Incontinence focused on measuring urge incontinence, biofeedback, pelvic floor muscle training, behavior modification

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: ambulatory women over age 60, who are incontinent at least twice weekly for 3 months despite correction of potentially reversible causes. urinary incontinence (urge or predominantly urge) by clinical criteria. able to accurately complete a voiding diary, to perform a 24-hour pad test under direction, and to undergo instruction in biofeedback. Exclusion Criteria: significant mental impairment [mini mental status exam (MMSE) ≤ 20) urethral obstruction history of bladder cancer spinal cord lesions multiple sclerosis pelvic radiation interstitial cystitis artificial sphincter implant expected to have changes in medications/doses during the trial medically unstable Patients with factors that could cause transient UI [e.g., current urinary tract infection (UTI), acute confusion] will be treated in concert with the subject's primary care provider and considered for enrollment if their UI persists. conditions that require endocarditis prophylaxis (such as heart valve problems or bacterial endocarditis) being unable to undergo fMRI because of claustrophobia or any metallic objects in the body, such pacemakers, metallic prostheses, aneurism clips or others.

Sites / Locations

  • Geriatric Continence Research Unit, NE547 Montefiore UPMC

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Biofeedback

Arm Description

Biofeedback assisted pelvic floor muscle therapy (3 visits)

Outcomes

Primary Outcome Measures

Percentage reduction in urge incontinence episodes at 12 weeks

Secondary Outcome Measures

Various urodynamic parameters such as, e.g.:
Increase in functional bladder capacity at 12 weeks
Volume at first detrusor overactivity at 12 weeks
Improvement in QoL at 12 weeks

Full Information

First Posted
September 13, 2005
Last Updated
August 4, 2017
Sponsor
University of Pittsburgh
Collaborators
National Institutes of Health (NIH), National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00177541
Brief Title
Further Enhancing Non-pharmacologic Therapy for Incontinence
Official Title
Further Enhancing Non-pharmacologic Therapy for Incontinence
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
February 2004 (undefined)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institutes of Health (NIH), National Institute on Aging (NIA)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To determine the mechanisms mediating the therapeutic efficacy of pelvic floor muscle exercises and biofeedback for urge urinary incontinence, as well as the characteristics of patients most likely to respond. By identifying the key components of this treatment, we hope to simplify it and make it more easily applicable, more effective, less expensive, and thus more useful for people with urge incontinence in the future.
Detailed Description
Urinary incontinence (UI) is prevalent and morbid in the elderly, and its associated costs exceed $26 billion annually. Although effective therapy exists, it is underutilized. This is particularly true for non-pharmacologic therapies, which are at least as effective as drugs but safer, and recommended as the initial approach by every national panel. If therapies such as biofeedback (which targets pelvic muscles and detrusor suppression) are to become more widely used, they will require simplification, fewer and briefer sessions, less expensive equipment, and less sophisticated therapists. Unfortunately, such protocols cannot yet be devised because it is unknown which components are essential. We postulate that the mechanisms mediating effectiveness can be identified and that such knowledge will make it possible to enhance efficacy and to formulate more feasible and cost-effective protocols. Since reduction in UI correlates weakly with improved quality of life, however, it is important that biofeedback's impact on life quality be assessed concomitantly to ensure that formulation of such streamlined methods does not eliminate components essential for improved quality of life, even if they have no physiological correlates. We will address these issues by treating at least 150 elderly subjects with urge UI in an 8-week course of biofeedback. We will collect clinical and quality of life data and perform extensive physiologic testing on each subject at baseline and 8 weeks later. Improvement will be correlated with change in physiologic and quality of life parameters to identify the parameters that likely mediated it. Knowledge from this study should identify predictors and mechanisms mediating success of biofeedback; suggest ways that it could be further improved; facilitate development of less expensive, quicker, and more feasible protocols to deliver it (potentially permitting application to less motivated or cognitively impaired patients); and shed insight into mechanisms that may even improve efficacy of other interventions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urge Urinary Incontinence
Keywords
urge incontinence, biofeedback, pelvic floor muscle training, behavior modification

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
123 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Biofeedback
Arm Type
Experimental
Arm Description
Biofeedback assisted pelvic floor muscle therapy (3 visits)
Intervention Type
Behavioral
Intervention Name(s)
Biofeedback, pelvic floor muscle training, fMRI
Intervention Description
Biofeedback, pelvic floor muscle training, fMRI
Primary Outcome Measure Information:
Title
Percentage reduction in urge incontinence episodes at 12 weeks
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Various urodynamic parameters such as, e.g.:
Time Frame
12 weeks
Title
Increase in functional bladder capacity at 12 weeks
Time Frame
12 weeks
Title
Volume at first detrusor overactivity at 12 weeks
Time Frame
12 weeks
Title
Improvement in QoL at 12 weeks
Time Frame
12 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ambulatory women over age 60, who are incontinent at least twice weekly for 3 months despite correction of potentially reversible causes. urinary incontinence (urge or predominantly urge) by clinical criteria. able to accurately complete a voiding diary, to perform a 24-hour pad test under direction, and to undergo instruction in biofeedback. Exclusion Criteria: significant mental impairment [mini mental status exam (MMSE) ≤ 20) urethral obstruction history of bladder cancer spinal cord lesions multiple sclerosis pelvic radiation interstitial cystitis artificial sphincter implant expected to have changes in medications/doses during the trial medically unstable Patients with factors that could cause transient UI [e.g., current urinary tract infection (UTI), acute confusion] will be treated in concert with the subject's primary care provider and considered for enrollment if their UI persists. conditions that require endocarditis prophylaxis (such as heart valve problems or bacterial endocarditis) being unable to undergo fMRI because of claustrophobia or any metallic objects in the body, such pacemakers, metallic prostheses, aneurism clips or others.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Neil M Resnick, MD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Becky Clarkson, PhD
Organizational Affiliation
University of Pittsburgh
Official's Role
Study Director
Facility Information:
Facility Name
Geriatric Continence Research Unit, NE547 Montefiore UPMC
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
9863850
Citation
Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, Candib D. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998 Dec 16;280(23):1995-2000. doi: 10.1001/jama.280.23.1995.
Results Reference
background
PubMed Identifier
9863856
Citation
Resnick NM. Improving treatment of urinary incontinence. JAMA. 1998 Dec 16;280(23):2034-5. doi: 10.1001/jama.280.23.2034. No abstract available.
Results Reference
background
PubMed Identifier
23168606
Citation
Resnick NM, Perera S, Tadic S, Organist L, Riley MA, Schaefer W, Griffiths D. What predicts and what mediates the response of urge urinary incontinence to biofeedback? Neurourol Urodyn. 2013 Jun;32(5):408-15. doi: 10.1002/nau.22347. Epub 2012 Nov 20.
Results Reference
derived

Learn more about this trial

Further Enhancing Non-pharmacologic Therapy for Incontinence

We'll reach out to this number within 24 hrs